Outcome of Frail Do-Not-Intubate Subjects With End-Stage Chronic Respiratory Failure and Their Opinion of Noninvasive Ventilation to Reverse Hypercapnic Coma.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 21 3 2019
medline: 31 7 2020
entrez: 21 3 2019
Statut: ppublish

Résumé

The use of noninvasive ventilation (NIV) in the emergency setting to reverse hypercapnic coma in frail patients with end-stage chronic respiratory failure and do-not-intubate orders remains a questionable issue given the poor outcome of this vulnerable population. We aimed to answer this issue by assessing not only subjects' outcome with NIV but also subjects' point of view regarding NIV for this indication. A prospective observational case-control study was conducted in 3 French tertiary care hospitals during a 2-y period. Forty-three individuals who were comatose (with pH < 7.25 and P NIV yielded similar outcomes in the 2 groups regarding in-hospital mortality ( In the frailest subjects with supposed end-stage chronic respiratory failure that justifies treatment limitation decisions, it is worth trying NIV when acute hypercapnic respiratory failure occurs, even in the case of extreme respiratory acidosis with hypercapnic coma at admission.

Sections du résumé

BACKGROUND BACKGROUND
The use of noninvasive ventilation (NIV) in the emergency setting to reverse hypercapnic coma in frail patients with end-stage chronic respiratory failure and do-not-intubate orders remains a questionable issue given the poor outcome of this vulnerable population. We aimed to answer this issue by assessing not only subjects' outcome with NIV but also subjects' point of view regarding NIV for this indication.
METHODS METHODS
A prospective observational case-control study was conducted in 3 French tertiary care hospitals during a 2-y period. Forty-three individuals who were comatose (with pH < 7.25 and P
RESULTS RESULTS
NIV yielded similar outcomes in the 2 groups regarding in-hospital mortality (
CONCLUSIONS CONCLUSIONS
In the frailest subjects with supposed end-stage chronic respiratory failure that justifies treatment limitation decisions, it is worth trying NIV when acute hypercapnic respiratory failure occurs, even in the case of extreme respiratory acidosis with hypercapnic coma at admission.

Identifiants

pubmed: 30890633
pii: respcare.06346
doi: 10.4187/respcare.06346
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1023-1030

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have disclosed no conflicts of interest.

Auteurs

Malcolm Lemyze (M)

Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France. malcolmlemyze@yahoo.fr.
Intensive Care Unit, Arras Hospital, Arras, France.

Gaël De Palleja (G)

Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France.
Respiratory Intermediate Care Unit, Schaffner Hospital, Lens, France.

Aurélie Guiot (A)

Department of Cardiology, Bois Bernard Hospital, Rouvroy, France.

Quentin Bury (Q)

Respiratory Intermediate Care Unit, Beuvry Hospital, Béthune, France.

Marie Jonard (M)

Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France.
Intensive Care Unit, Arras Hospital, Arras, France.

Maxime Granier (M)

Intensive Care Unit, Arras Hospital, Arras, France.

Didier Thevenin (D)

Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France.
Intensive Care Unit, Arras Hospital, Arras, France.

Jihad Mallat (J)

Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France.
Intensive Care Unit, Arras Hospital, Arras, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH